OP2LYSIS DEVELOPMENT

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1461490.0,
      "delta_eur": 400000.0,
      "before_eur": 1061490.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "OP2LYSIS",
          "share_class": null,
          "liberation_pct": 25.0,
          "contribution_kind": "numeraire",
          "n_shares_subscribed": 650,
          "contribution_amount_eur": 400000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 650,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 615.0
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 100000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": 300000.0,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-01-17",
    "filing_date": "2024-01-15",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-12-06",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0769.816.843",
    "name_full": "OP2LYSIS DEVELOPMENT",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procuration",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [
    {
      "kbo": "0769.816.843",
      "pct": 100.0,
      "kind": "org",
      "name": "OP2LYSIS DEVELOPMENT",
      "role": "aandeelhouder",
      "n_shares": 2376,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1061490.0,
      "delta_eur": 999990.0,
      "before_eur": 61500.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "GAUDIN Christophe",
          "share_class": null,
          "liberation_pct": 25.0,
          "contribution_kind": "numeraire",
          "n_shares_subscribed": 1626,
          "contribution_amount_eur": 999990.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 1626,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 615.0
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 249997.5,
      "n_shares_destroyed": null,
      "not_yet_called_eur": 749992.5,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-11-29",
    "filing_date": "2022-11-25",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-11-15",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2022-11-15"
  },
  "bedrijfsrevisor": {
    "waived": true,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": "none",
    "individual_name": null
  },
  "subject_company": {
    "kbo": "0769.816.843",
    "name_full": "OP2LYSIS DEVELOPMENT",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "GAUDIN Christophe",
      "role": null,
      "n_shares": 1626,
      "share_class": null
    }
  ],
  "share_classes_after": []
}